GL1X · GenesisL1 explorer

MolNFT v1 · #31062 · protein

Structure of a non-peptide inhibitor complexed with HIV-1 protease: developing a cycle of structure-based drug design

2AID · Human immunodeficiency virus protease: “Structure of a non-peptide inhibitor complexed with HIV-1 protease: developing a cycle of structure-based…”. X-ray diffraction, 2 ligands (THK, CL), 1 pocket (best druggability 0.69). MolNFT…

PDB
2AID
Type
protein
Length
198 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Human immunodeficiency virus protease
EC
3.4.23.16
UniProt
P03369
Ligands
THK, CL
Pockets
1 · best druggability 0.69

Structure

x-ray diffraction · 1 distinct chain · 6% helix, 52% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BHuman immunodeficiency virus protease (EC 3.4.23.16)protein996% helix, 52% strandP03369

Ligands and binding sites

  • THK · 4-(4-chloro-phenyl)-1-{3-[2-(4-fluoro-phenyl)-[1,3]dithiolan-2-yl]-propyl}-piperidin-4-ol · ligand · 2 copies · chains A, B
  • CL · Chloride ion · ion · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14020.690.8134CL, THK

Interfaces

1 interface between chains.

  • A–B · 1803 Ų buried · 43 hydrogen bonds · protein-protein

Compared structures

  • 2AID · Structure of a non-peptide inhibitor complexed with HIV-1 protease: developing a cycle of… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.